Search results

@BigTex It seems that I am reading different user reports from yours. I really do not care of "broscience" type reports - any drug for them is good. I have tried BPC-157 for "gut health" and it didn't work. Two other people confirmed in this thread it didn't work for them either. In fact, I...

Proving drug safety and effectiveness requires good quality research, not an expensive trial for FDA approval, so that excuse for the really low quality, missing, or contradictory "research" on BPC-157 doesn't fly. Nobody wants it to be FDA approved, but everyone should demand it is well...

Are you currently injecting TRT?

Actually the US patent was obtained in 2013: https://patents.google.com/patent/US9850282B2/en

This thread is not about FDA or CDC approvals or what anyone thinks of their process. I personally do not care if a drug is not FDA approved, as long as it has consistent research demonstrating that it is safe and effective. This is not the case of BPC-157. The "research" on BPC-157 appears...

Just found out why Rabeprazole was giving me these severe headaches during the H. Pylori eradication protocol. ChatGPT cited articles that Rabeprazole increased the HSV-1 and HSV-2 DNA viral loads 2-4 times in patients with Recurrent aphthous stomatitis (HSV-1) and recurrent genital herpes...

The point of this thread is that there are no human studies proving safety and effectiveness of BPC-157 and all the human "research" that is proudly stated on sites selling peptides consists of canceled and unpublished "trials". The lack of funding argument does not apply, because there aren't...

A wide gap seems to exist between claims and reality with BPC-157. What the above sales representative won't tell you is that to this day, 30 years after the "discovery", there are NO human studies of BPC-157 for gastric problems because all such human trials ended up canceled and not...

A Phase II study for BPC-157 in the form of enemas for Inflammatory Bowel Disease was started in 2002 and again radio silence after that, no results published, no phase III study initiated, which means they did not like the result or have safety concerns...

They did not need it to absorb. It was a pre-trial for for BPC-157 in Ulcerative colitis, which requires topical action, not absorption. Yet nothing published in 8 years except some poster in Digestive Disease Week 2023 that few can access: https://adisinsight.springer.com/drugs/800006013

BPC-157 and its drug delivery variations have quite a few patents already. If there was a "lack of funding" then they wouldn't start a Phase 1 trial and complete it, which is extremely cheap in Mexico. Since the trial was completed and the results not published, the only logical conclusion is...

The fact that they did not publish any result and did nothing for 8 years after the trial in 2015 means that the drug company thinks the drug is not marketable or has safety concerns. This is the usual history of failing drugs.

Phase I, pilot study in healthy volunteers, to assess the safety and pharmacokinetics of PCO-02, which active ingredient is BPC-157, a pentadecapeptide from gastric source. Conducted in 2015. Canceled in 2016 with NO EXPLANATION - either not effective or dangerous...

And the sales representative keeps spewing nonsense "studies" from Croatia or China ... Promoting VEGFR by BPC-157 is begging for cancer: https://www.sciencedirect.com/science/article/pii/S1044579X22000670 "Body Protective Compound" it is NOT! That is why the team in Croatia is afraid to do a...